Clinical Trial Update: Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating reduced fluence photodynamic therapy with Visudyne in combination with Lucentis for age-related macular degeneration; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Oklahoma State University Center for Health Sciences | Conditions: Age-Related Maculopathy, Choroidal Neovascularization | Phase 4 | Status: COMPLETED | Results posted: 2012-11-08